A

AbbVie

Global biopharmaceutical company developing medicines

Head Global Oncology Pipeline - Medical Affairs

Biology & BiotechConfirmed live in the last 24 hours
Full-time

About the Job

Requirements

  • An M.D. or equivalent advanced degree in a relevant scientific discipline, such as oncology or hematology.
  • At least 15 years of experience in the pharmaceutical or biotechnology industry, focused on oncology, specifically hematology.
  • Demonstrated expertise in clinical development, regulatory requirements, and commercialization of oncology therapies.
  • Proven leadership experience in medical affairs, including managing direct and indirect reports, cross-functional teams, and influencing strategic direction at the senior executive level.
  • Strong scientific knowledge of solid tumor biology, clinical trial design, biomarker development, and emerging treatment modalities such as immuno-oncology, targeted therapies, and precision medicine.
  • Ability to collaborate cross-functionally with clinical development, regulatory, commercial, and other business functions.
  • Experience presenting complex scientific information to technical and non-technical stakeholders.
  • Ability to travel domestically and internationally up to 25–30%.

Responsibilities

  • Lead global pipeline medical affairs strategy and develop differentiation across the lifecycle, using market insights to shape therapeutic-area pipeline strategy.
  • Shape initial value and evidence strategy and initiate evidence-generation plans using insights from payors, patients, and physicians; direct the pipeline execution team to implement strategy with enterprise research medical science liaisons.
  • Collaborate with international therapeutic areas, global therapeutic area business units, and development counterparts.
  • Represent the therapeutic area in pipeline governance when aligned with the therapeutic area business unit head.
  • Work with operations and medical engagement teams to operationalize pipeline strategy.
  • Lead medical, value, and evidence strategy development for the therapeutic area's pipeline, including business development, across disease areas and indications or brands for United States and international markets, up to 24–36 months before launch.
  • Differentiate medical, value, and evidence strategies from discovery onward using insights from United States and international markets.
  • Coordinate across therapeutic areas so their pipeline strategies form a coherent enterprise pipeline strategy.
  • Incorporate healthcare professional, patient, and payor insights into development programs to accelerate and differentiate clinical and commercialization strategies, including streamlined patient data collection and patient finding.
  • Co-create brand strategy for all assets and incorporate United States and international market insights.
  • Represent medical affairs in pipeline governance as the single point of contact for commercial and development counterparts.
  • Serve as the final decision maker before the business unit head for pipeline-related strategy and decisions.
  • Manage pipeline resources and redirect the pipeline team to enterprise-critical assets throughout the lifecycle, beginning as early as discovery.
  • Ensure effective handover to United States and international inline and launch teams, onboarding with relevant therapeutic areas to share pipeline strategy insights and approaches and reduce duplicated effort.
  • Lead cross-functional gap assessment and integrated evidence planning, collaborating with Value and Evidence.
  • Define strategy and priorities for enterprise research medical science liaisons in the United States and affiliates, and shape their tactical plans using pipeline insights.
  • Coordinate with the United States medical engagement pipeline execution group to drive execution.
  • Work with United States medical engagement to track impact-focused key performance indicators and adjust pipeline strategy based on impact and best practices.

Desired Qualifications

  • Familiarity with advanced cancer treatment modalities such as CAR-T therapies, combination therapies, and immuno-oncology.
  • A strong publication and scientific communication record in oncohematology, including contributions to peer-reviewed journals and major oncology conferences.
  • Experience managing global medical affairs activities across multiple geographic regions, focused on global strategy and the United States region.

About the Company

AbbVie

Global biopharmaceutical company developing medicines

AbbVie is a global biopharmaceutical company that develops and sells medicines to treat serious health conditions. Its portfolio spans immunology, oncology, virology, neuroscience, and aesthetics, with products designed to modulate the immune system, target disease pathways, or support medical aesthetics. AbbVie compounds its products through a heavy emphasis on research and development, investing billions to build a steady pipeline of new therapies. Its medicines are brought to market by selling to healthcare providers, hospitals, and clinics, and in some cases directly to patients via prescriptions. The company differentiates itself through a wide, globally distributed product line, substantial R&D investment, and a commitment to sustainability and patient care, including science-based targets. AbbVie’s goal is to improve patient outcomes by delivering effective treatments for unmet medical needs while pursuing long-term, responsible growth across healthcare markets.

Company size
10,001+
Company stage
IPO
Headquarters
North Chicago, IL
Founded
1888

Recently Posted Jobs

Explore more opportunities at AbbVie

See more jobs